Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC


- Citation:
- J Thorac Oncol vol 12 (11, suppl 2) S2285–86
- Meeting Instance:
- IASLC (WCLC) 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Funding:
- AFT
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None